Strategic Partnership with Jaffe Sports Medicine Includes Four Locations in West Florida
Shore Capital Partners (“Shore”), a private equity firm, is pleased to announce it has founded Southern Sports Medicine Partners (“SSMP”), through the completion of a strategic partnership with Jaffe Sports Medicine (“JSM”). SSMP provides interventional pain management practices with administrative support, so physicians can focus on delivering the highest quality of patient care.
JSM, led by founder Dr. Peter Jaffe, provides patient-centric care at four locations in the Naples, FL area. Mike Cooper, a founding partner of Shore, commented, “We are thrilled to partner with Dr. Jaffe. He is one of the most respected and well-known physicians in West Florida. Having built a world-class practice, Dr. Jaffe shares our vision to deliver clinical excellence at greater scale.”
Dr. Jaffe said, “I partnered with Shore for their track record of transformational growth in healthcare and a shared belief in what it will take to be the leading interventional pain management platform in the Southeast. As healthcare continues to become more retail and consumer-oriented, the time is ideal to embrace growth, patient experience, and best in class programs and options for physicians in all stages of their careers. Southern Sports Medicine Partners is off to a great start and I have high aspirations for what we can achieve.”
SSMP will grow its platform across the region by investing in people and processes to support the operations, finance, accounting, marketing, human resources, and IT functions at affiliated practices, thereby allowing physicians to focus on clinical excellence and serving their communities. SSMP will pursue affiliations with independent interventional pain management practices to build a network of top clinicians in a physician-led culture.
“We are building a leader of scale in pain management and sports medicine, starting with Dr. Jaffe and his team,” said Mr. Cooper. “We are well-positioned to support the continued transition to consumer-directed healthcare, while maintaining the physician’s role and clinical expertise as the most critical aspect of treatment. Additionally, Shore has helped to bring together an exceptional board of directors consisting of industry thought leaders and physicians alike to guide our strategy and growth plan.”
SSMP represents the third platform investment out of Shore Capital Partners Fund III, L.P., a $293 million investment vehicle raised in April 2019.
To learn more about Jaffe Sports Medicine, please visit www.jaffesportsmedicine.com.
About Shore Capital
Shore Capital Partners is a Chicago-based private equity firm focused on microcap Healthcare and Food and Beverage investments. Shore supports management partners with capital, business development expertise, and industry knowledge to accelerate growth, fund acquisitions, and generate value to shareholders. Shore targets investments in proven, successful private companies with superior management teams, stable cash flow, and significant growth potential, including organic and growth through industry consolidation. Shore has $1.1 billion of equity capital under management through various investment vehicles. For more information on Shore, please visit www.shorecp.com.
View source version on businesswire.com: https://www.businesswire.com/news/home/20201102005029/en/
Los Angeles County public health officials on Sunday reported 1,590 new cases of the coronavirus and four related deaths.
The numbers brought the county’s total to 309,197 cases and 7,074 deaths.
There were 799 confirmed coronavirus patients in county hospitals on Friday, with 28% in intensive care, officials said. Though hospitalizations have increased slightly, they remain far below the 2,220-plus patients seen during the peak of the outbreak in July.
Still, many Southern California communities are reporting increases in the number of cases recorded each day, a concerning trend that has some officials worried that transmission of the virus could be on the rise.
In order to determine when a county can move to the next phase of reopening under California’s four-tier plan, the state monitors how many cases have been reported per 100,000 residents over a recent seven-day period. In larger counties, the rate is adjusted to account for how much testing is being done.
L.A. County’s adjusted case rate increased last week to eight per 100,000 residents, from 7.6 the week before.
In Orange County, which reported 233 new coronavirus cases and one death Sunday, the case rate ticked up to 5.1 from 4.6 the week before. Riverside County reported its most recent adjusted case rate at 10.1, up from 9.1 the week before. And San Bernardino County reported an adjusted case rate of 11.9, up from 10.9.
L.A., Riverside and San Bernardino counties all remain in the purple tier, the most restrictive, meaning risk of transmission remains widespread, and most nonessential businesses are closed for indoor operations. To move into the next tier, red, a county must have an adjusted rate of no more than seven cases per 100,000 residents.
Orange County is classified within the red tier. In order to move into the less-restrictive orange tier, which means that the risk of transmission is considered moderate and some indoor business operations can resume with modifications, the county must reduce its adjusted case rate to four cases per 100,000 residents.
It’s not clear what is driving the increase in cases in Southern California. Some officials have blamed parties as likely contributors, particularly gatherings celebrating the recent Lakers and Dodgers wins.
The trend is also playing out elsewhere across the United States, which on Thursday broke the single-day record for the highest number of coronavirus cases, then did so again Friday.
This story originally appeared in Los Angeles Times.
Clinician reads radiology images
October 26, 2020
Philips Clinical Collaboration Platform supports telehealth and other connectivity initiatives to increase collaboration across hospitals
Amsterdam, The Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced the completion of a regional informatics project that consolidates radiology and nuclear medicine imaging data. The Region of Southern Denmark now has a single system for storing, retrieving, and viewing clinical images across all the locations and specialties in its extensive healthcare system.
The Region of Southern Denmark health service encompasses four hospital groups with a total of 12 hospitals that serve a population of over 1.2 million people living on both on the mainland and the region’s many islands. The unified imaging ecosystem will serve all of the region’s approximately 300 radiologists and nuclear medicine specialists, performing 1.5 million exams yearly. The related images are now accessible to the over 5,000 clinicians in the region.
“Easy access to medical patient data across complex healthcare systems fosters clinical collaboration and is essential to advance precision diagnosis,” said Calum Cunningham, General Manager of Enterprise Diagnostic Informatics at Philips. “We were able to implement our Enterprise Imaging solution in record time, helping the Region of Southern Denmark to move to the next step of digital maturity, improve collaboration, and ultimately enhance patient care.”
“An important requirement was solid integration with the national image registry in Region Sjælland,” said Jørgen Balle Kristensen, Senior IT Project Manager for the Region of Southern Denmark. “The Philips Vendor-Neutral Archive has an open, standards-based design that’s compatible with images in virtually any clinical format, from any source, so it’s a perfect fit for our integration needs.”
The region decided to partner with Philips to advance its digital transformation towards precision diagnosis. The adoption of Philips Enterprise Imaging solutions has started with implementing the Philips Vendor-Neutral Archive (VNA) and Philips Universal Viewer as part of its strategy to replace the existing systems. These modules provide a single source of archiving and distribution of imaging information that enables viewing of clinical images virtually, anytime anywhere by authorized users via a web browser or mobile device.
Philips Enterprise Imaging solutions combine scalable, modular architecture that integrates with existing systems to deliver data and tools across and beyond the enterprise – from radiology data reporting to enterprise-wide ingestion, distribution and archiving, to full patient and clinical data management. It consolidates multiple specialty workstations into a single, multifunctional workspace that allows radiologists to enhance reporting quality. For more information, visit https://www.philips.com/collaboration.
For further information, please contact:
Philips Global Press Office
Tel. : +31 6 10610417
E-mail : [email protected]
About Royal Philips
Royal Philips (NYSE: PHG, AEX: PHIA) is a leading health technology company focused on improving people’s health and well-being, and enabling better outcomes across the health continuum – from healthy living and prevention, to diagnosis, treatment and home care. Philips leverages advanced technology and deep clinical and consumer insights to deliver integrated solutions. Headquartered in the